Chapter 6 - The Fall of Whitfield Medical
Within forty-eight hours of the deposition, the final hammer fell.
The federal judge denied bail, citing Marcus as a severe flight risk after investigators discovered he had attempted to wire $4 million to an offshore account in the Cayman Islands. He was remanded to a federal holding facility to await trial.
Without its figurehead and with its core patent invalidated, Whitfield Medical Analytics declared bankruptcy. The company’s stock crashed to zero overnight.
The board of directors, desperate to salvage whatever reputation remained, held an emergency asset liquidation auction.
On a bright Tuesday morning, Ethan and I walked into the bankruptcy court bidding room. Among the corporate buyers and venture capitalists, we were the only ones who held the true master key.
When the primary software architecture and asset holdings of Whitfield Medical were put on the block, Ethan placed a single, crushing bid through Aegis Health: $100 million in cash, backed by the full financial power of Rhodes Capital.
No one dared to bid against us.
With a single strike of the gavel, I officially reclaimed every piece of code, every algorithm, every server, and every patent that had been stolen from me three years prior.
As we walked out of the courtroom, reporters thronged the marble steps. Cameras flashed incessantly.
"Mrs. Rhodes! Mrs. Rhodes!" a reporter yelled, thrusting a microphone toward me. "How does it feel to buy back the company that your ex-husband used to build his empire?"
May you like
I stopped on the steps, wind rustling my hair, looking straight into the news cameras.
"I didn't buy back an empire," I said calmly. "I simply reclaimed my work. And from today, Whitfield Medical Analytics is no more. It is now Aegis Diagnostic Sciences—a company dedicated to saving lives, built on integrity, truth, and genuine innovation."
